Tech Company Financing Transactions

Auspex Pharmaceuticals Funding Round

On 1/8/2014, Auspex Pharmaceuticals secured $20 million in Series E funding from Deerfield Capital, BioMed Ventures and Costa Verde Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series E

Deerfield Capital (Lead Investor) (Jonathan Leff)

BioMed Ventures

Costa Verde Capital

Panorama Capital (Gaurav Aggarwal)

Presidio Partners (David Collier)

Thomas, McNerny & Partners (Pratik Shah)

Proceeds Purpose
These financings strengthen the balance sheet as we advance SD-809, our lead program, in Phase 3 clinical development for the treatment of chorea associated with Huntington's disease.

Company Information

Company Status
Acquired or Merged
Mailing Address
3366 North Torrey Pines Ct. 225
La Jolla, CA 92037
Email Address
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
Auspex Pharmaceuticals LinkedIn Company Profile
Social Media
Auspex Pharmaceuticals Company Twitter Account
Company News
Auspex Pharmaceuticals News
Auspex Pharmaceuticals on Facebook
Auspex Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Pratik Shah
  Pratik Shah LinkedIn Profile  Pratik Shah Twitter Account  Pratik Shah News  Pratik Shah on Facebook
Chief Financial Officer
John Schmid
  John Schmid LinkedIn Profile  John Schmid Twitter Account  John Schmid News  John Schmid on Facebook
Chief Medical Officer
David Stamler
  David Stamler LinkedIn Profile  David Stamler Twitter Account  David Stamler News  David Stamler on Facebook
Chief Operating Officer
Bharatt Chowrira
  Bharatt Chowrira LinkedIn Profile  Bharatt Chowrira Twitter Account  Bharatt Chowrira News  Bharatt Chowrira on Facebook
Chief Operating Officer
Andreas Sommer
  Andreas Sommer LinkedIn Profile  Andreas Sommer Twitter Account  Andreas Sommer News  Andreas Sommer on Facebook



Browse more venture capital transactions:

Prev: 1/8/2014: ChowNow venture capital transaction
Next: 1/9/2014: Immedia Semiconductor venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary